About us

about us

Index Ventures

Index Ventures is a leading global venture capital firm active in technology and biotechnology venture investing since 1996. In the life science field, Index invests in companies with disruptive platform technologies capable of growing into global leaders. It has also pioneered the “asset-centric” investment model, focused on investing in single assets with the potential to be first or best in class.

In March 2012, Index launched its first fund dedicated to life sciences. The $200 million fund includes investment from GlaxoSmithKline (GSK) and the venture capital affiliate of Janssen pharmaceutical companies, part of Johnson & Johnson.